De-escalating Breast Cancer Surgery-Where Is the Tipping Point?

被引：17
|
作者：
Morrow, Monica [1 ]
Winer, Eric P. [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, 300 E 66th St, New York, NY 10065 USA
[2] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
来源：
JAMA ONCOLOGY | 2020年 / 6卷 / 02期
关键词：
SURVIVAL; THERAPY; WOMEN;
D O I：
10.1001/jamaoncol.2019.4849
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This Viewpoint provides a perspective on recent trials focused on reducing the incidence of surgery in the treatment of breast cancer.
引用
收藏
页码：183 / 184
页数：2
相关论文
共 50 条
  • [21] Escalating and de-escalating treatments in HR+HER2- early-stage breast cancer
    Ge, Rui
    TRANSLATIONAL BREAST CANCER RESEARCH, 2022, 3
  • [22] Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer
    Gianni, Caterina
    Palleschi, Michela
    Merloni, Filippo
    Bleve, Sara
    Casadei, Chiara
    Sirico, Marianna
    Di Menna, Giandomenico
    Sarti, Samanta
    Cecconetto, Lorenzo
    Mariotti, Marita
    De Giorgi, Ugo
    CANCERS, 2023, 15 (01)
  • [23] De-Escalating Breast Cancer Surgery: Should We Apply Quality Indicators from Other Jurisdictions in Canada?
    Kapur, Hannah
    Chen, Leo
    Warburton, Rebecca
    Pao, Jin-Si
    Dingee, Carol
    Kuusk, Urve
    Bazzarelli, Amy
    McKevitt, Elaine
    CURRENT ONCOLOGY, 2022, 29 (01) : 144 - 154
  • [24] De-escalating treatment with neoadjuvant chemotherapy in early triple-negative breast cancer
    Murillo, Serafin Morales
    Cudos, Ariadna Gasol
    Der-Abrain, Noemi Tuset
    CANCER RESEARCH, 2024, 84 (09)
  • [25] De-escalating chemotherapy for stage II colon cancer?
    Fu, Jianfei
    Wu, Lunpo
    Ge, Chenyang
    Xu, Tiantian
    Li, Dan
    Fu, Wei
    Wang, Liangjing
    Du, Jinlin
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [26] The Evolving Approach to Breast Cancer: Moving toward De-Escalating Treatment and Personalized Medicine
    Khoury, Thaer
    CANCERS, 2023, 15 (13)
  • [27] De-escalating doses of letrozole in post menopausal women at high risk for breast cancer
    Lopez, Ana Maria
    Chow, Hsiao Hui Sherry
    Frank, Denise
    Puthi, Sandhya
    Boughey, Judy
    Hsu, Paul
    Guillen, Jose
    Perloff, Marjorie
    Ley, Michelle
    Lang, Julie E.
    CANCER RESEARCH, 2015, 75
  • [28] De-escalating systemic therapy in triple negative breast cancer: The example of secretory carcinoma
    Benabu, J-C
    Stoll, F.
    Koch, A.
    Moliere, S.
    Bellocq, J-P
    Mathelin, C.
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2018, 47 (04) : 163 - 165
  • [29] ER+/HER2+breast cancer: are we really de-escalating?
    de Azambuja, E.
    Piccart-Gebhart, M.
    ANNALS OF ONCOLOGY, 2019, 30 (06) : 875 - 877
  • [30] De-escalating treatment in the adjuvant setting in HER2-positive breast cancer
    Barroso-Sousa, Romualdo
    Exman, Pedro
    Tolaney, Sara M.
    FUTURE ONCOLOGY, 2018, 14 (10) : 937 - 945
12345